Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alexander L. Shiang"'
Autor:
Alexander L. Shiang, Joshua K. Palka, Shiva Balasubramanian, R. Sherburne Figenshau, Zachary L. Smith, Eric H. Kim
Publikováno v:
Journal of Robotic Surgery. 17:835-840
Dissemination of robotic surgical technology for robot-assisted laparoscopic prostatectomy (RALP) has yielded advancements including the Retzius-sparing (RS) approach and the single-port (SP) platform. The safety and feasibility of each individual ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::410ecbd1c0cccf7d20d9b98e1e7c6ade
https://doi.org/10.1007/s11701-022-01464-z
https://doi.org/10.1007/s11701-022-01464-z
Autor:
Pradeep Singh Chauhan, Alexander L. Shiang, Irfan Alahi, R. Taylor Sundby, Wenjia Feng, Bilge Gungoren, Cayce Nawaf, Kevin Chen, Ramandeep K. Babbra, Peter K. Harris, Faridi Qaium, Casey Hatscher, Anna Antiporda, Lindsey Brunt, Lindsey R. Mayer, Jack F. Shern, Brian C. Baumann, Eric H. Kim, Melissa A. Reimers, Zachary L. Smith, Aadel A. Chaudhuri
Publikováno v:
Cancer Research. 83:2219-2219
Background: Circulating cell-free tumor DNA (ctDNA) analysis for minimal residual disease (MRD) detection is transforming cancer care. However, the sensitivity of these approaches remains subpar and there is significant risk of false negative results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8149d03600f4e2d7b4b6d839cba8268b
https://doi.org/10.1158/1538-7445.am2023-2219
https://doi.org/10.1158/1538-7445.am2023-2219
Autor:
Irfan Alahi, Pradeep S. Chauhan, Alexander L. Shiang, Jace Webster, Ha X. Dang, Lilli Greiner, Breanna yang, Elisa M. Ledet, Ramandeep K. Babbra, Wenjia Feng, Peter K. Harris, Ellen B. Jaeger, Patrick J. Miller, Sydney A. Caputo, Giordano Cittolin Santos, Oliver Sartor, Russell K. Pachynski, Christopher A. Maher, Aadel A. Chaudhuri
Publikováno v:
Cancer Research. 83:6698-6698
Background: Androgen receptor signaling inhibitors (ARSI) such abiraterone and enzalutamide have significantly improved clinical outcomes in metastatic castrate-resistant prostate cancer (mCRPC) patients. However, patients with genomic alterations in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d70f446636ba8df37b0cd4c85c749968
https://doi.org/10.1158/1538-7445.am2023-6698
https://doi.org/10.1158/1538-7445.am2023-6698